Tuberculosis Prevalence Surveys PDF Download

Author: World Health Organization
Publisher:
ISBN: 9789241548168
Category : Medical
Languages : en
Pages : 0

View

Book Description
Rev. ed. of: Assessing tuberculosis prevalence through population-based surveys. 2007.

Author:
Publisher: World Health Organization
ISBN: 9240022430
Category : Medical
Languages : en
Pages : 291

View

Book Description
Between 2007 and the end of 2016, 24 countries implemented a total of 25 national tuberculosis prevalence surveys using methods recommended by WHO. The 25 surveys consisted of 13 in Asia and 12 in Africa. Collectively, survey findings have informed the policies, plans and programmatic actions needed to address gaps in TB diagnosis and treatment and to reduce the burden of TB disease. Finally, the 24 countries have a robust baseline for assessing progress towards new global targets set in the UN Sustainable Development Goals (2016–2030) and WHO’s End TB Strategy (2016–2035). The methods, results, successes achieved, challenges faced and lessons learned from the 25 surveys were comprehensively documented in the book. We viewed such a product as a global public good, that should be available to all those with an interest in and commitment to using survey findings, now and in the future e.g. academics, donors, public health officers and national TB programmes. As with implementation of the 25 surveys themselves, the book is the result of a major global, regional and national collaborative and collective effort, with more than 450 contributors from all around the world.

Author: Who Regional Office for the Western Pacific
Publisher: World Health Organization
ISBN: 9290613149
Category : Medical
Languages : en
Pages : 249

View

Book Description
This publication provides countries with practical guidelines for planning population-based surveys to estimate the prevalence of tuberculosis (TB) at a national level. TB prevalence surveys yield useful information in areas where notification data obtained through routine surveillance are incomplete, or of unproven accuracy, and in areas with an estimated TB prevalence of more than 100 per 100 000. These surveys are used to evaluate the performance of the TB program, and to assess trends over time. To achieve this objective, data are collected through standards methods in a well-defined study population. This document is meant to provide information on the core survey methods, including diagnostic tests for TB, screening strategies, and case definitions. The target audience includes TB experts and advisers at national and international levels, and investigators involved in prevalence surveys.

Author: World Health Organization
Publisher: World Health Organization
ISBN: 9240073914
Category : Medical
Languages : en
Pages : 48

View

Book Description

Author: Dean T. Jamison
Publisher: World Bank Publications
ISBN: 0821363980
Category : Medical
Languages : en
Pages : 414

View

Book Description
Current data and trends in morbidity and mortality for the sub-Saharan Region as presented in this new edition reflect the heavy toll that HIV/AIDS has had on health indicators, leading to either a stalling or reversal of the gains made, not just for communicable disorders, but for cancers, as well as mental and neurological disorders.

Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241548606
Category : Medical
Languages : en
Pages : 140

View

Book Description
There have been calls to revisit the experiences of TB screening campaigns that were widely applied in Europe and North America in the mid-20th century, as well as more recent experiences with TB screening in countries with a high burden of the disease, and to assess their possible relevance for TB care and prevention in the 21st century. In response, WHO has developed guidelines on screening for active TB. An extensive review of the evidence has been undertaken. The review suggests that screening, if done in the right way and targeting the right people, may reduce suffering and death, but the review also highlights several reasons to be cautious. As discussed in detail in this book, there is a need to balance potential benefits against the risks and costs of screening; this conclusion is mirrored by the history of TB screening. This publication presents the first comprehensive assessment by WHO of the appropriateness of screening for active TB since the recommendations made in 1974 by the Expert Committee. However, the relative effectiveness and cost effectiveness of screening remain uncertain, a point that is underscored by the systematic reviews presented in this guideline. Evidence suggests that some risk groups should always be screened, whereas the prioritization of other risk groups as well as the choice of screening approach depend on the epidemiology, the health-system context, and the resources available. This book sets out basic principles for prioritizing risk groups and choosing a screening approach; it also emphasizes the importance of assessing the epidemiological situation, adapting approaches to local situations, integrating TB screening into other health-promotion activities, minimizing the risk of harm to individuals, and engaging in continual monitoring and evaluation. It calls for more and better research to assess the impact of screening and to develop and evaluate new screening tests and approaches.

Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241564652
Category : Medical
Languages : en
Pages : 303

View

Book Description
This is the eighteenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention care and control at global regional and country levels using data reported by almost 200 countries that account for over 99% of the world's TB cases. Two years before the 2015 deadline for achievement of global TB targets the 2013 report includes a special supplement that assesses progress towards the 2015 targets and the actions needed to accelerate towards or move beyond them.The report has 8 main chapters. The introductory chapter provides general background on TB as well as an explanation of global targets for TB control the WHO's Stop TB Strategy that covers the period 2006-2015 and the development of a post-2015 global TB strategy. The remaining seven chapters cover the disease burden caused by TB (incidence prevalence mortality); TB case notifications and treatment outcomes; drug resistance surveillance among TB patients and the programmatic response in detecting and providing treatment for multidrug-resistant TB; diagnostics and laboratory strengthening for TB; addressing the co-epidemics of TB and HIV; financing TB care and control; and research and development for new TB diagnostics drugs and vaccines.The four annexes of the report include a thorough explanation of methods used to estimate the burden of disease caused by TB one-page profiles for 22 high TB-burden countries and tables of data on key indicators for all countries organized by WHO region.

Author: King K. Holmes
Publisher: World Bank Publications
ISBN: 1464805253
Category : Medical
Languages : en
Pages : 506

View

Book Description
Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

Author: World Health Organization
Publisher:
ISBN: 9789241506700
Category : Medical
Languages : en
Pages : 0

View

Book Description
In December 2010, WHO first recommended the use of the Xpert MTB/RIF assay. The WHO's policy statement was supported by a rapid implementation document, which provided the technical "how-to" and operational considerations for rolling out the use of the assay. An unprecedented uptake of this new technology followed the release of WHO's policy: by the end of March 2014, more than 2,300 GeneXpert instruments and more than 6 million Xpert MTB/RIF cartridges had been procured in the public sector in 104 countries eligible for concessional prices. An Expert Group was convened by WHO in May 2013 to review the current body of evidence on use of Xpert MTB/RIF. The resulting recommendations from the Expert Group are included in the WHO Policy update, which widens the recommended use of Xpert MTB/RIF, including for the diagnosis of paediatric TB and on selected specimens for the diagnosis of extrapulmonary TB, and includes an additional recommendation on the use of Xpert MTB/RIF as the initial diagnostic test in all individuals presumed to have pulmonary TB. The accompanying Xpert MTB/RIF implementation manual has been developed to replace the first edition and takes into consideration the current body of evidence and operational experiences available, in the context of the Policy update.

Author: World Health Organization
Publisher: World Health Organization
ISBN: 9241565640
Category : Medical
Languages : en
Pages : 277

View

Book Description
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic and of progress in prevention diagnosis and treatment of the disease at global regional and country levels. This is done in the context of recommended global TB strategies and targets endorsed by WHO?s Member States and broader development goals set by the United Nations (UN). The 2018 edition of the global TB report was released on 18 September in the lead up to the first-ever UN High Level Meeting on TB on 26 September 2018.